BridgeBio Oncology Therapeutics Inc (BBOT)

BridgeBio Oncology Therapeutics Inc has recorded no insider trading activity within the past ninety days. The most recent transactions occurred on February 13, 2024, when CEO and Chairperson Chen Bihua executed multiple significant share purchases. These historical acquisitions represent the final documented internal movements for the firm.
Ticker: BBOT Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
279.69
Quantity 78,056 -2.7%
Value US$4,191,097
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
288.68
Quantity 37,098 +22.9%
Value US$2,394,048
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
480.13
Quantity 20,375 +39.3%
Value US$2,428,918
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
78,056 -2.7%
279.69
US$4,191,097
78,056 -2.7% 279.69 US$4,191,097
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
37,098 +22.9%
288.68
US$2,394,048
37,098 +22.9% 288.68 US$2,394,048
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
20,375 +39.3%
480.13
US$2,428,918
20,375 +39.3% 480.13 US$2,428,918